Research substances, often known as "novel psychoactive compounds," present a complex challenge due to their evolving nature. These substances are typically synthesized for scientific exploration, but are often encountered in the party drug market. The lack of extensive data on their long-term effects means users face considerable physical risks, w

The proliferation of designer drugs is significantly becoming a worry for public health officials . These compounds , often marketed as replacements to illicit materials, frequently are missing comprehensive data regarding their potential risks. Their availability online and through back-alley channels presents a grave threat to community health an